CLOROX CO /DE/ financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
CLX on NYSE
Location
Oakland, CA
Fiscal year end
30 June
Latest financial report
03 Feb 2026

Quick Takeaways

  • CLX - CLOROX CO /DE/ financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 987%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-112%</span>.
  • Most recent SEC facts end date: 20 Jan 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-01-20) highlights Return On Equity 987.2%, Return On Assets 11.3%, and Operating Margin 14.0%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

64.2/100

Balanced Confidence high

Return On Equity

987%

Metric score 100.0/100

Return On Assets

11%

Metric score 100.0/100

Financial Health

Current Ratio
0.74x
Quick Ratio
0.38x
Debt to Equity
91.91x

Strengths

Return On Equity, Return On Assets, and Current Ratio

Watchpoints

Debt-to-equity and Revenues YoY

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Equity 987% -112%
Return On Assets 11% +70%
Operating Margin 14%

Financial Health

Metric Latest value YoY change
Current Ratio 0.74x -22%
Quick Ratio 0.38x -21%
Debt-to-equity 91.91x +116%

Growth

Metric Latest value YoY change
Revenues YoY -5.7%
NetIncomeLoss YoY 65%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 120,911,863 -1.8%
Common Stock, Shares, Outstanding 120,890,241 -1.8%
Common Stock, Value, Issued $131,000,000 0%
Weighted Average Number of Shares Outstanding, Basic 121,602,000 -1.7%
Weighted Average Number of Shares Outstanding, Diluted 121,915,000 -2.2%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $6,758,000,000 -5.7%
Research and Development Expense $116,000,000 -8.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $986,000,000 +52%
Income Tax Expense (Benefit) $216,000,000 +21%
Earnings Per Share, Basic 6.15 +67%
Earnings Per Share, Diluted 6.12 +67%
Cash and Cash Equivalents, at Carrying Value $227,000,000 -22%
Inventory, Net $608,000,000 +2.7%
Assets, Current $1,728,000,000 +5.9%
Property, Plant and Equipment, Net $1,247,000,000 +0.4%
Operating Lease, Right-of-Use Asset $368,000,000 +1.7%
Goodwill $1,231,000,000 +0.98%
Other Assets, Noncurrent $483,000,000 -12%
Assets $5,613,000,000 +0.65%
Liabilities, Current $2,347,000,000 +36%
Deferred Income Tax Liabilities, Net $19,000,000 -14%
Operating Lease, Liability, Noncurrent $341,000,000 +0.59%
Other Liabilities, Noncurrent $385,000,000 -56%
Liabilities $5,578,000,000 +2.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $159,000,000 +12%
Retained Earnings (Accumulated Deficit) $190,000,000 +179%
Stockholders' Equity Attributable to Parent $125,000,000 -205%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $35,000,000 -71%
Liabilities and Equity $5,613,000,000 +0.65%
Share-based Payment Arrangement, Noncash Expense $24,000,000 -11%
Common Stock, Shares Authorized 750,000,000 0%
Common Stock, Shares, Issued 130,741,461 0%
Common Stock, Par or Stated Value Per Share 1 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $229,000,000 -22%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $777,000,000 +22%
Operating Lease, Liability, Current $83,000,000 +2.5%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Preferred Stock, Shares Outstanding 0
Depreciation, Depletion and Amortization $55,000,000 +3.8%
Interest Expense $93,000,000 +8.1%
Preferred Stock, Par or Stated Value Per Share 1 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY